During the past decade, GOGiunta ophtalmologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "GOGiunta ophtalmologie" #1 collaborator was "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "GOGiunta ophtalmologie" are "Glaucoma, Open-Angle" (1 trials), "Neovascular (Wet) Age-related Macular Degeneration" (1 trials), "Neovascular Age-related Macular Degeneration" (1 trials), "Ocular Hypertension" (1 trials) and "Wet Macular Degeneration" (1 trials). Many other conditions were trialed in "GOGiunta ophtalmologie" in a lesser frequency.

Most popular intervention types in "GOGiunta ophtalmologie" are "Drug" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "Sham Procedure" (2 trials), "Active Comparator: Timolol 0.5%" (1 trials), "Aflibercept" (1 trials) and "Aflibercept(BAY86-5321, Eylea)" (1 trials). Other intervention names were less common.

The vast majority of trials in "GOGiunta ophtalmologie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "GOGiunta ophtalmologie". 1 are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in GOGiunta ophtalmologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GOGiunta ophtalmologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".